Modeling familial cancer with induced pluripotent stem cells

Cell

Volumn 161, Issue 2, 2015, Pages 240-254

  Lee, Dung Fang ^a   Su, Jie ^a   Kim, Huen Suk ^a   Chang, Betty ^a   Papatsenko, Dmitri ^a   Zhao, Ruiying ^b   Yuan, Ye ^a   Gingold, Julian ^a   Xia, Weiya ^b   Darr, Henia ^a   Mirzayans, Razmik ^c   Hung, Mien Chie ^b,d   Schaniel, Christoph ^a   Lemischka, Ihor R ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF ALBERTA   (Canada)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DECORIN; PROTEIN P53; DCN PROTEIN, HUMAN; H19 LONG NON-CODING RNA; LONG UNTRANSLATED RNA; TP53 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; CANCER MODEL; CANCER SURVIVAL; CARCINOGENESIS; CELL DIFFERENTIATION; CONTROLLED STUDY; FAMILIAL CANCER; FUNCTIONAL GENOMICS; GAIN OF FUNCTION MUTATION; GENE EXPRESSION; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; OSTEOSARCOMA; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; TUMOR RECURRENCE; UPREGULATION; ADOLESCENT; ADULT; ANIMAL; BIOLOGICAL MODEL; CANCER TRANSPLANTATION; CHILD; COMPLICATION; CYTOLOGY; FEMALE; GENE REGULATORY NETWORK; GENETICS; MALE; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; XENOGRAFT;

ADOLESCENT; ADULT; ANIMALS; CHILD; DECORIN; FEMALE; GENE REGULATORY NETWORKS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; LI-FRAUMENI SYNDROME; MALE; MESENCHYMAL STROMAL CELLS; MICE; MODELS, BIOLOGICAL; NEOPLASM TRANSPLANTATION; OSTEOBLASTS; OSTEOGENESIS; OSTEOSARCOMA; RNA, LONG NONCODING; TRANSPLANTATION, HETEROLOGOUS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84927155547     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2015.02.045     Document Type: Article

References (59)

1. T. Barberi, L.M. Willis, N.D. Socci, and L. Studer Derivation of multipotent mesenchymal precursors from human embryonic stem cells PLoS Med. 2 2005 e161
2. R.D. Barley, L. Enns, M.C. Paterson, and R. Mirzayans Aberrant p21WAF1-dependent growth arrest as the possible mechanism of abnormal resistance to ultraviolet light cytotoxicity in Li-Fraumeni syndrome fibroblast strains heterozygous for TP53 mutations Oncogene 17 1998 533 543
3. J.R. Batanian, L.R. Cavalli, N.M. Aldosari, E. Ma, C. Sotelo-Avila, M.B. Ramos, J.D. Rone, C.M. Thorpe, and B.R. Haddad Evaluation of paediatric osteosarcomas by classic cytogenetic and CGH analyses MP, Mol. Pathol. 55 2002 389 393
4. J.A. Bridge, P.S. Bhatia, J.R. Anderson, and J.R. Neff Biologic and clinical significance of cytogenetic and molecular cytogenetic abnormalities in benign and malignant cartilaginous lesions Cancer Genet. Cytogenet. 69 1993 79 90
5. S. Choufani, C. Shuman, and R. Weksberg Beckwith-Wiedemann syndrome Am. J. Med. Genet. C. Semin. Med. Genet. 154C 2010 343 354
6. C.J. Di Como, C. Gaiddon, and C. Prives p73 function is inhibited by tumor-derived p53 mutants in mammalian cells Mol. Cell. Biol. 19 1999 1438 1449
7. T. Dugimont, C. Montpellier, E. Adriaenssens, S. Lottin, L. Dumont, V. Iotsova, C. Lagrou, D. Stéhelin, J. Coll, and J.J. Curgy The H19 TATA-less promoter is efficiently repressed by wild-type tumor suppressor gene product p53 Oncogene 16 1998 2395 2401
8. T. Eggermann Russell-Silver syndrome Am. J. Med. Genet. C. Semin. Med. Genet. 154C 2010 355 364
9. W.A. Freed-Pastor, and C. Prives Mutant p53: one name, many proteins Genes Dev. 26 2012 1268 1286
10. N. Fusaki, H. Ban, A. Nishiyama, K. Saeki, and M. Hasegawa Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome Proc. Jpn. Acad., Ser. B, Phys. Biol. Sci. 85 2009 348 362
11. A. Gabory, M.A. Ripoche, A. Le Digarcher, F. Watrin, A. Ziyyat, T. Forné, H. Jammes, J.F. Ainscough, M.A. Surani, L. Journot, and L. Dandolo H19 acts as a trans regulator of the imprinted gene network controlling growth in mice Development 136 2009 3413 3421
12. C. Gaiddon, M. Lokshin, J. Ahn, T. Zhang, and C. Prives A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain Mol. Cell. Biol. 21 2001 1874 1887
13. W. Hanel, N. Marchenko, S. Xu, S.X. Yu, W. Weng, and U. Moll Two hot spot mutant p53 mouse models display differential gain of function in tumorigenesis Cell Death Differ. 20 2013 898 909
14. Y. Hao, T. Crenshaw, T. Moulton, E. Newcomb, and B. Tycko Tumour-suppressor activity of H19 RNA Nature 365 1993 764 767
15. R.C. Haydon, H.H. Luu, and T.C. He Osteosarcoma and osteoblastic differentiation: a new perspective on oncogenesis Clin. Orthop. Relat. Res. 454 2007 237 246
16. J.A. Joyce, and P.N. Schofield Genomic imprinting and cancer MP, Mol. Pathol. 51 1998 185 190
17. G.A. Lang, T. Iwakuma, Y.A. Suh, G. Liu, V.A. Rao, J.M. Parant, Y.A. Valentin-Vega, T. Terzian, L.C. Caldwell, and L.C. Strong Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome Cell 119 2004 861 872
18. D.F. Lee, J. Su, Y.S. Ang, X. Carvajal-Vergara, S. Mulero-Navarro, C.F. Pereira, J. Gingold, H.L. Wang, R. Zhao, and A. Sevilla Regulation of embryonic and induced pluripotency by aurora kinase-p53 signaling Cell Stem Cell 11 2012 179 194
19. C.J. Lengner, H.A. Steinman, J. Gagnon, T.W. Smith, J.E. Henderson, B.E. Kream, G.S. Stein, J.B. Lian, and S.N. Jones Osteoblast differentiation and skeletal development are regulated by Mdm2-p53 signaling J. Cell Biol. 172 2006 909 921
20. F.P. Li, and J.F. Fraumeni Jr. Rhabdomyosarcoma in children: epidemiologic study and identification of a familial cancer syndrome J. Natl. Cancer Inst. 43 1969 1365 1373
21. Q. Lian, E. Lye, K. Suan Yeo, E. Khia Way Tan, M. Salto-Tellez, T.M. Liu, N. Palanisamy, R.M. El Oakley, E.H. Lee, B. Lim, and S.K. Lim Derivation of clinically compliant MSCs from CD105+, CD24- differentiated human ESCs Stem Cells 25 2007 425 436
22. O. Lustig-Yariv, E. Schulze, D. Komitowski, V. Erdmann, T. Schneider, N. de Groot, and A. Hochberg The expression of the imprinted genes H19 and IGF-2 in choriocarcinoma cell lines. Is H19 a tumor suppressor gene? Oncogene 15 1997 169 177
23. D. Malkin, F.P. Li, L.C. Strong, J.F. Fraumeni Jr., C.E. Nelson, D.H. Kim, J. Kassel, M.A. Gryka, F.Z. Bischoff, and M.A. Tainsky Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms Science 250 1990 1233 1238
24. R. Mirzayans, B. Andrais, A. Scott, M.C. Paterson, and D. Murray Single-cell analysis of p16(INK4a) and p21(WAF1) expression suggests distinct mechanisms of senescence in normal human and Li-Fraumeni Syndrome fibroblasts J. Cell. Physiol. 223 2010 57 67
25. A. Molchadsky, N. Rivlin, R. Brosh, V. Rotter, and R. Sarig p53 is balancing development, differentiation and de-differentiation to assure cancer prevention Carcinogenesis 31 2010 1501 1508
26. K.P. Olive, D.A. Tuveson, Z.C. Ruhe, B. Yin, N.A. Willis, R.T. Bronson, D. Crowley, and T. Jacks Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome Cell 119 2004 847 860
27. D.E. Porter, S.T. Holden, C.M. Steel, B.B. Cohen, M.R. Wallace, and R. Reid A significant proportion of patients with osteosarcoma may belong to Li-Fraumeni cancer families J. Bone Joint Surg. Br. 74 1992 883 886
28. B. Sosa-García, V. Gunduz, V. Vázquez-Rivera, W.D. Cress, G. Wright, H. Bian, P.W. Hinds, and P.G. Santiago-Cardona A role for the retinoblastoma protein as a regulator of mouse osteoblast cell adhesion: implications for osteogenesis and osteosarcoma formation PLoS ONE 5 2010 e13954
29. K. Takahashi, and S. Yamanaka Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors Cell 126 2006 663 676
30. K. Takahashi, K. Tanabe, M. Ohnuki, M. Narita, T. Ichisaka, K. Tomoda, and S. Yamanaka Induction of pluripotent stem cells from adult human fibroblasts by defined factors Cell 131 2007 861 872
31. N. Tang, W.X. Song, J. Luo, R.C. Haydon, and T.C. He Osteosarcoma development and stem cell differentiation Clin. Orthop. Relat. Res. 466 2008 2114 2130
32. J.M. Varley Germline TP53 mutations and Li-Fraumeni syndrome Hum. Mutat. 21 2003 313 320
33. A. Varrault, C. Gueydan, A. Delalbre, A. Bellmann, S. Houssami, C. Aknin, D. Severac, L. Chotard, M. Kahli, and A. Le Digarcher Zac1 regulates an imprinted gene network critically involved in the control of embryonic growth Dev. Cell 11 2006 711 722
34. A.J. Verkerk, I. Ariel, M.C. Dekker, T. Schneider, R.J. van Gurp, N. de Groot, A.J. Gillis, J.W. Oosterhuis, A.A. Hochberg, and L.H. Looijenga Unique expression patterns of H19 in human testicular cancers of different etiology Oncogene 14 1997 95 107
35. C.R. Walkley, R. Qudsi, V.G. Sankaran, J.A. Perry, M. Gostissa, S.I. Roth, S.J. Rodda, E. Snay, P. Dunning, and F.H. Fahey Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease Genes Dev. 22 2008 1662 1676
36. X. Wang, H.Y. Kua, Y. Hu, K. Guo, Q. Zeng, Q. Wu, H.H. Ng, G. Karsenty, B. de Crombrugghe, J. Yeh, and B. Li p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodeling J. Cell Biol. 172 2006 115 125
37. L. Yi, C. Lu, W. Hu, Y. Sun, and A.J. Levine Multiple roles of p53-related pathways in somatic cell reprogramming and stem cell differentiation Cancer Res. 72 2012 5635 5645
38. T. Yoshimizu, A. Miroglio, M.A. Ripoche, A. Gabory, M. Vernucci, A. Riccio, S. Colnot, C. Godard, B. Terris, H. Jammes, and L. Dandolo The H19 locus acts in vivo as a tumor suppressor Proc. Natl. Acad. Sci. USA 105 2008 12417 12422
39. J. Yu, M.A. Vodyanik, K. Smuga-Otto, J. Antosiewicz-Bourget, J.L. Frane, S. Tian, J. Nie, G.A. Jonsdottir, V. Ruotti, and R. Stewart Induced pluripotent stem cell lines derived from human somatic cells Science 318 2007 1917 1920
40. Y.S. Ang, S.Y. Tsai, D.F. Lee, J. Monk, J. Su, K. Ratnakumar, J. Ding, Y. Ge, H. Darr, and B. Chang Wdr5 mediates self-renewal and reprogramming via the embryonic stem cell core transcriptional network Cell 145 2011 183 197
41. J.P. Brunet, P. Tamayo, T.R. Golub, and J.P. Mesirov Metagenes and molecular pattern discovery using matrix factorization Proc. Natl. Acad. Sci. USA 101 2004 4164 4169
42. X. Carvajal-Vergara, A. Sevilla, S.L. D'Souza, Y.S. Ang, C. Schaniel, D.F. Lee, L. Yang, A.D. Kaplan, E.D. Adler, and R. Rozov Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome Nature 465 2010 808 812
43. A.D. Kelly, B. Haibe-Kains, K.A. Janeway, K.E. Hill, E. Howe, J. Goldsmith, K. Kurek, A.R. Perez-Atayde, N. Francoeur, and J.B. Fan MicroRNA paraffin-based studies in osteosarcoma reveal reproducible independent prognostic profiles at 14q32 Genome Med 5 2013 2
44. W.J. Kent, C.W. Sugnet, T.S. Furey, K.M. Roskin, T.H. Pringle, A.M. Zahler, and D. Haussler The human genome browser at UCSC Genome Res. 12 2002 996 1006
45. B. Langmead, C. Trapnell, M. Pop, and S.L. Salzberg Ultrafast and memory-efficient alignment of short DNA sequences to the human genome Genome Biol. 10 2009 R25
46. D.F. Lee, J. Su, A. Sevilla, J. Gingold, C. Schaniel, and I.R. Lemischka Combining competition assays with genetic complementation strategies to dissect mouse embryonic stem cell self-renewal and pluripotency Nat. Protoc. 7 2012 729 748
47. E. Lopez-Rivera, P. Jayaraman, F. Parikh, M.A. Davies, S. Ekmekcioglu, S. Izadmehr, D.R. Milton, J.E. Chipuk, E.A. Grimm, and Y. Estrada Inducible nitric oxide synthase drives mTOR pathway activation and proliferation of human melanoma by reversible nitrosylation of TSC2 Cancer Res. 74 2014 1067 1078
48. M. Reich, T. Liefeld, J. Gould, J. Lerner, P. Tamayo, and J.P. Mesirov GenePattern 2.0 Nat. Genet. 38 2006 500 501
49. A. Roberts, H. Pimentel, C. Trapnell, and L. Pachter Identification of novel transcripts in annotated genomes using RNA-Seq Bioinformatics 27 2011 2325 2329
50. A. Roberts, C. Trapnell, J. Donaghey, J.L. Rinn, and L. Pachter Improving RNA-Seq expression estimates by correcting for fragment bias Genome Biol. 12 2011 R22
51. Y. Sasaki, Y. Oshima, R. Koyama, M. Tamura, L. Kashima, M. Idogawa, T. Yamashita, M. Toyota, K. Imai, Y. Shinomura, and T. Tokino A novel approach to cancer treatment using structural hybrids of the p53 gene family Cancer Gene Ther. 19 2012 749 756
52. G. Smith, F.A. Carey, J. Beattie, M.J. Wilkie, T.J. Lightfoot, J. Coxhead, R.C. Garner, R.J. Steele, and C.R. Wolf Mutations in APC, Kirsten-ras, and p53 - alternative genetic pathways to colorectal cancer Proc. Natl. Acad. Sci. USA 99 2002 9433 9438
53. M.E. Smoot, K. Ono, J. Ruscheinski, P.L. Wang, and T. Ideker Cytoscape 2.8: new features for data integration and network visualization Bioinformatics 27 2011 431 432
54. J.M. Stuart, E. Segal, D. Koller, and S.K. Kim A gene-coexpression network for global discovery of conserved genetic modules Science 302 2003 249 255
55. A.I. Su, T. Wiltshire, S. Batalov, H. Lapp, K.A. Ching, D. Block, J. Zhang, R. Soden, M. Hayakawa, and G. Kreiman A gene atlas of the mouse and human protein-encoding transcriptomes Proc. Natl. Acad. Sci. USA 101 2004 6062 6067
56. C.M. Tan, E.Y. Chen, R. Dannenfelser, N.R. Clark, and A. Ma'ayan Network2Canvas: network visualization on a canvas with enrichment analysis Bioinformatics 29 2013 1872 1878
57. P.D. Thomas, M.J. Campbell, A. Kejariwal, H. Mi, B. Karlak, R. Daverman, K. Diemer, A. Muruganujan, and A. Narechania PANTHER: a library of protein families and subfamilies indexed by function Genome Res. 13 2003 2129 2141
58. C. Trapnell, L. Pachter, and S.L. Salzberg TopHat: discovering splice junctions with RNA-Seq Bioinformatics 25 2009 1105 1111
59. C. Trapnell, B.A. Williams, G. Pertea, A. Mortazavi, G. Kwan, M.J. van Baren, S.L. Salzberg, B.J. Wold, and L. Pachter Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation Nat. Biotechnol. 28 2010 511 515